Your Article Summary
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease
Respiratory Medicine, 07/01/09
Higashimoto Y et al. - Serum CRP and MMP-9 levels were related to FEV1 decline. These markers are good candidates as predictors for rapid decline of FEV1 in COPD patients. Additional long-term and larger size studies of COPD patients could help determine the exact roles for these biomarkers.
Related Articles
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09
Relevance Score: 92%
Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease
Medical Hypotheses, 10/08/09
Relevance Score: 91%
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09
Relevance Score: 90%
Tiotropium HandiHaler in the treatment of COPD: A safety review
International Journal of COPD, 10/29/09
Relevance Score: 89%
Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying
Palliative Medicine, 10/16/09
Relevance Score: 89%
Today in Pulmonology...keeping you current
Receive free subspecialty "5-minute updates" via email
Health status measurement in exacerbations of COPD
Expert Review of Respiratory Medicine, 12/11/09
Lung disease at high altitude
Expert Review of Respiratory Medicine, 12/11/09
Classic Respiratory Disease but Atypical Diagnostic Testing Distinguishes Adult Presentation of Cystic Fibrosis
Chest, 12/11/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
The relation between serotonin levels and insufficient blood pressure decrease during night-time in hypertensive patients
Blood Pressure, 12/11/09
Contributions of blood pressure to proteinuria and renal function in the puerperium
Blood Pressure, 12/11/09
Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Mayo Clinic Proceedings, 12/11/09

See Latest Articles